title: Dissociation of cellular proliferation and c-myc expression by buttercup extract.
abstract: Buttercup extract (BE), an extract of the buttercup plant (Zanthoriza simplicissima), inhibits RNA and DNA synthesis by HL-60 promyelocytic leukemia cells. Exposure of these cells to 3% BE for 48 hours results in dramatic inhibition of RNA synthesis without loss of cell viability. The effect of BE is partially reversible over 12-24 hours with the level of RNA synthesis returning nearly to control levels during this time period. DNA synthesis is also reversibly inhibited by exposure to BE. Despite the inhibition of RNA synthesis in HL-60 cells, there is no decrease in the level of c-myc mRNA, even at high BE concentrations. The level of gene-specific mRNA for the c-Ha-ras, c-fms, and c-mos genes in these cells also remained constant during exposure to BE. Ribosomal RNA is not degraded during 24 hours of BE treatment in vitro, suggesting that BE does not maintain the relative mRNA level for these genes by selective degradation of other RNA species. The inhibition of RNA and DNA synthesis by BE without a corresponding alteration in the level of expression of the c-myc gene suggests that this agent dissociates c-myc expression and cellular proliferation in these cells.
authors.affiliation: Bolden Laboratory, Comprehensive Cancer Center, University of Alabama, Birmingham.
authors.forename: V
authors.initials: V
authors.lastname: Baker
authors.forename: K
authors.initials: K
authors.lastname: Shrestha
authors.forename: S
authors.initials: S
authors.lastname: Thomas
authors.forename: D
authors.initials: D
authors.lastname: Rigsbee
authors.forename: D
authors.initials: D
authors.lastname: Hunter
authors.forename: J
authors.initials: J
authors.lastname: Sanchez
authors.forename: R
authors.initials: R
authors.lastname: Wheeler
authors.forename: D M
authors.initials: DM
authors.lastname: Miller
mesh_terms: D002455:Cell Division / Q000187:drug effects; D002822:Choriocarcinoma / Q000235:genetics / Q000473:pathology; D003536:Cystadenocarcinoma / Q000235:genetics / Q000473:pathology; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005069:Evaluation Studies as Topic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics / Q000473:pathology; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology; D010936:Plant Extracts / Q000494:pharmacology*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D013997:Time Factors; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured
chemical_list: D004273:DNA, Neoplasm; D010936:Plant Extracts; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D012335:RNA, Ribosomal